Bristol-Myers Squibb Company PFD CONV 2 (BMYMP)
USD 998.89
(0.0%)
USD 998.89
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 41.46 Billion USD | 1.83% |
| 2022 | 40.71 Billion USD | -10.7% |
| 2021 | 45.59 Billion USD | -11.76% |
| 2020 | 51.67 Billion USD | 8.7% |
| 2019 | 47.53 Billion USD | 546.86% |
| 2018 | 7.34 Billion USD | -7.7% |
| 2017 | 7.96 Billion USD | 18.69% |
| 2016 | 6.7 Billion USD | 0.28% |
| 2015 | 6.68 Billion USD | -14.59% |
| 2014 | 7.83 Billion USD | -6.09% |
| 2013 | 8.34 Billion USD | 12.79% |
| 2012 | 7.39 Billion USD | 34.66% |
| 2011 | 5.49 Billion USD | 0.84% |
| 2010 | 5.44 Billion USD | -14.4% |
| 2009 | 6.36 Billion USD | -5.61% |
| 2008 | 6.73 Billion USD | 7.45% |
| 2007 | 6.27 Billion USD | -15.64% |
| 2006 | 7.43 Billion USD | -13.5% |
| 2005 | 8.59 Billion USD | -16.92% |
| 2004 | 10.34 Billion USD | 19.62% |
| 2003 | 8.64 Billion USD | 13.21% |
| 2002 | 7.64 Billion USD | 19.17% |
| 2001 | 6.41 Billion USD | 327.97% |
| 2000 | 1.49 Billion USD | -15.56% |
| 1999 | 1.77 Billion USD | -3.9% |
| 1998 | 1.84 Billion USD | 1.32% |
| 1997 | 1.82 Billion USD | 23.19% |
| 1996 | 1.47 Billion USD | 22.23% |
| 1995 | 1.21 Billion USD | -11.61% |
| 1994 | 1.36 Billion USD | 78.95% |
| 1993 | 765 Million USD | 38.84% |
| 1992 | 551 Million USD | -19.91% |
| 1991 | 688 Million USD | 9.55% |
| 1990 | 628 Million USD | 21.24% |
| 1989 | 518 Million USD | -46.21% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 54 Billion USD | -5.93% |
| 2024 Q1 | 57.4 Billion USD | 38.46% |
| 2024 Q3 | 49.75 Billion USD | -4.82% |
| 2023 Q2 | 39.18 Billion USD | -0.47% |
| 2023 FY | 41.46 Billion USD | 1.83% |
| 2023 Q4 | 41.46 Billion USD | 5.6% |
| 2023 Q3 | 39.26 Billion USD | 0.21% |
| 2023 Q1 | 39.37 Billion USD | -3.31% |
| 2022 Q4 | 40.71 Billion USD | 1.51% |
| 2022 Q3 | 40.11 Billion USD | -6.81% |
| 2022 FY | 40.71 Billion USD | -10.7% |
| 2022 Q2 | 43.04 Billion USD | -6.42% |
| 2022 Q1 | 45.99 Billion USD | 0.88% |
| 2021 Q1 | 47.26 Billion USD | -8.52% |
| 2021 Q2 | 46.29 Billion USD | -2.06% |
| 2021 Q3 | 45.84 Billion USD | -0.97% |
| 2021 Q4 | 45.59 Billion USD | -0.54% |
| 2021 FY | 45.59 Billion USD | -11.76% |
| 2020 FY | 51.67 Billion USD | 8.7% |
| 2020 Q1 | 47.53 Billion USD | -0.02% |
| 2020 Q2 | 47.51 Billion USD | -0.04% |
| 2020 Q3 | 45.8 Billion USD | -3.58% |
| 2020 Q4 | 51.67 Billion USD | 12.81% |
| 2019 Q1 | 6.05 Billion USD | -17.59% |
| 2019 Q2 | 25.04 Billion USD | 313.56% |
| 2019 Q4 | 47.53 Billion USD | 89.96% |
| 2019 Q3 | 25.02 Billion USD | -0.08% |
| 2019 FY | 47.53 Billion USD | 546.86% |
| 2018 Q2 | 7.38 Billion USD | -4.06% |
| 2018 FY | 7.34 Billion USD | -7.7% |
| 2018 Q4 | 7.34 Billion USD | 0.57% |
| 2018 Q3 | 7.3 Billion USD | -1.08% |
| 2018 Q1 | 7.7 Billion USD | -3.29% |
| 2017 Q1 | 8.43 Billion USD | 25.73% |
| 2017 Q2 | 8.21 Billion USD | -2.57% |
| 2017 Q3 | 8.44 Billion USD | 2.75% |
| 2017 Q4 | 7.96 Billion USD | -5.7% |
| 2017 FY | 7.96 Billion USD | 18.69% |
| 2016 Q4 | 6.7 Billion USD | -1.73% |
| 2016 FY | 6.7 Billion USD | 0.28% |
| 2016 Q1 | 6.69 Billion USD | 0.15% |
| 2016 Q2 | 6.73 Billion USD | 0.55% |
| 2016 Q3 | 6.82 Billion USD | 1.34% |
| 2015 FY | 6.68 Billion USD | -14.59% |
| 2015 Q4 | 6.68 Billion USD | -8.04% |
| 2015 Q3 | 7.27 Billion USD | -1.3% |
| 2015 Q2 | 7.37 Billion USD | -1.17% |
| 2015 Q1 | 7.45 Billion USD | -4.79% |
| 2014 Q2 | 7.73 Billion USD | 1.16% |
| 2014 Q3 | 7.66 Billion USD | -0.89% |
| 2014 FY | 7.83 Billion USD | -6.09% |
| 2014 Q1 | 7.64 Billion USD | -8.3% |
| 2014 Q4 | 7.83 Billion USD | 2.14% |
| 2013 Q3 | 7.21 Billion USD | 0.08% |
| 2013 Q1 | 7.89 Billion USD | 6.76% |
| 2013 FY | 8.34 Billion USD | 12.79% |
| 2013 Q4 | 8.34 Billion USD | 15.64% |
| 2013 Q2 | 7.2 Billion USD | -8.72% |
| 2012 Q1 | 5.41 Billion USD | -1.38% |
| 2012 Q2 | 5.44 Billion USD | 0.55% |
| 2012 Q3 | 7.35 Billion USD | 35.15% |
| 2012 Q4 | 7.39 Billion USD | 0.48% |
| 2012 FY | 7.39 Billion USD | 34.66% |
| 2011 Q3 | 5.61 Billion USD | 1.81% |
| 2011 FY | 5.49 Billion USD | 0.84% |
| 2011 Q2 | 5.51 Billion USD | 2.0% |
| 2011 Q1 | 5.41 Billion USD | -0.62% |
| 2011 Q4 | 5.49 Billion USD | -2.28% |
| 2010 Q1 | 6.28 Billion USD | -1.13% |
| 2010 FY | 5.44 Billion USD | -14.4% |
| 2010 Q4 | 5.44 Billion USD | 0.0% |
| 2010 Q2 | 6.53 Billion USD | 3.96% |
| 2009 Q1 | 6.64 Billion USD | -1.35% |
| 2009 Q2 | 6.35 Billion USD | -4.35% |
| 2009 Q4 | 6.36 Billion USD | -3.52% |
| 2009 Q3 | 6.59 Billion USD | 3.68% |
| 2009 FY | 6.36 Billion USD | -5.61% |
| 2008 Q3 | 6.25 Billion USD | -20.01% |
| 2008 FY | 6.73 Billion USD | 7.45% |
| 2008 Q1 | 6.44 Billion USD | 2.69% |
| 2008 Q2 | 7.82 Billion USD | 21.41% |
| 2008 Q4 | 6.73 Billion USD | 7.74% |
| 2007 Q3 | 6.12 Billion USD | -15.3% |
| 2007 Q1 | 7.37 Billion USD | -0.83% |
| 2007 Q2 | 7.23 Billion USD | -1.89% |
| 2007 FY | 6.27 Billion USD | -15.64% |
| 2007 Q4 | 6.27 Billion USD | 2.37% |
| 2006 Q1 | 8.51 Billion USD | -0.97% |
| 2006 Q3 | 8.46 Billion USD | 0.46% |
| 2006 FY | 7.43 Billion USD | -13.5% |
| 2006 Q2 | 8.42 Billion USD | -0.99% |
| 2006 Q4 | 7.43 Billion USD | -12.19% |
| 2005 FY | 8.59 Billion USD | -16.92% |
| 2005 Q2 | 6.3 Billion USD | -26.49% |
| 2005 Q3 | 6.17 Billion USD | -2.03% |
| 2005 Q4 | 8.59 Billion USD | 39.26% |
| 2005 Q1 | 8.57 Billion USD | -17.17% |
| 2004 Q4 | 10.34 Billion USD | 1.53% |
| 2004 FY | 10.34 Billion USD | 19.62% |
| 2004 Q3 | 10.19 Billion USD | 8.58% |
| 2004 Q2 | 9.38 Billion USD | -0.28% |
| 2004 Q1 | 9.41 Billion USD | 8.81% |
| 2003 Q3 | 8.7 Billion USD | 4.63% |
| 2003 Q2 | 8.32 Billion USD | -3.37% |
| 2003 FY | 8.64 Billion USD | 13.21% |
| 2003 Q1 | 8.61 Billion USD | 12.75% |
| 2003 Q4 | 8.64 Billion USD | -0.69% |
| 2002 Q4 | 7.64 Billion USD | 9.1% |
| 2002 Q3 | 7 Billion USD | 1.13% |
| 2002 FY | 7.64 Billion USD | 19.17% |
| 2002 Q2 | 6.92 Billion USD | 6.9% |
| 2002 Q1 | 6.47 Billion USD | 1.05% |
| 2001 Q3 | 7.99 Billion USD | 445.97% |
| 2001 Q2 | 1.46 Billion USD | -2.2% |
| 2001 FY | 6.41 Billion USD | 327.97% |
| 2001 Q1 | 1.49 Billion USD | -0.07% |
| 2001 Q4 | 6.41 Billion USD | -19.79% |
| 2000 Q3 | 1.49 Billion USD | -5.79% |
| 2000 Q2 | 1.58 Billion USD | -6.48% |
| 2000 Q1 | 1.69 Billion USD | -4.28% |
| 2000 FY | 1.49 Billion USD | -15.56% |
| 2000 Q4 | 1.49 Billion USD | 0.13% |
| 1999 FY | 1.77 Billion USD | -3.9% |
| 1999 Q4 | 1.77 Billion USD | -3.74% |
| 1999 Q3 | 1.84 Billion USD | -1.6% |
| 1999 Q1 | 1.9 Billion USD | 3.14% |
| 1999 Q2 | 1.87 Billion USD | -1.63% |
| 1998 Q2 | 1.78 Billion USD | -7.26% |
| 1998 FY | 1.84 Billion USD | 1.32% |
| 1998 Q4 | 1.84 Billion USD | 1.54% |
| 1998 Q3 | 1.81 Billion USD | 1.62% |
| 1998 Q1 | 1.92 Billion USD | 5.87% |
| 1997 Q2 | 1.59 Billion USD | 2.64% |
| 1997 Q1 | 1.55 Billion USD | 4.94% |
| 1997 Q4 | 1.82 Billion USD | 0.94% |
| 1997 FY | 1.82 Billion USD | 23.19% |
| 1997 Q3 | 1.8 Billion USD | 13.31% |
| 1996 Q2 | 1.06 Billion USD | -7.29% |
| 1996 Q3 | 1.15 Billion USD | 8.24% |
| 1996 Q4 | 1.47 Billion USD | 27.94% |
| 1996 FY | 1.47 Billion USD | 22.23% |
| 1996 Q1 | 1.15 Billion USD | -4.79% |
| 1995 Q1 | 1.46 Billion USD | 6.72% |
| 1995 Q2 | 1.51 Billion USD | 3.42% |
| 1995 Q4 | 1.21 Billion USD | -9.09% |
| 1995 Q3 | 1.33 Billion USD | -11.91% |
| 1995 FY | 1.21 Billion USD | -11.61% |
| 1994 Q2 | 857 Million USD | 2.27% |
| 1994 Q1 | 838 Million USD | 9.54% |
| 1994 Q4 | 1.36 Billion USD | -1.79% |
| 1994 FY | 1.36 Billion USD | 78.95% |
| 1994 Q3 | 1.39 Billion USD | 62.66% |
| 1993 FY | 765 Million USD | 38.84% |
| 1993 Q3 | 604 Million USD | -29.6% |
| 1993 Q1 | 491 Million USD | -10.89% |
| 1993 Q2 | 858 Million USD | 74.75% |
| 1993 Q4 | 765 Million USD | 26.66% |
| 1992 FY | 551 Million USD | -19.91% |
| 1992 Q2 | 531 Million USD | -8.61% |
| 1992 Q1 | 581 Million USD | -15.55% |
| 1992 Q4 | 551 Million USD | 1.1% |
| 1992 Q3 | 545 Million USD | 2.64% |
| 1991 Q1 | 547 Million USD | -12.9% |
| 1991 Q3 | 597 Million USD | 4.74% |
| 1991 Q4 | 688 Million USD | 15.24% |
| 1991 FY | 688 Million USD | 9.55% |
| 1991 Q2 | 570 Million USD | 4.2% |
| 1990 Q2 | 551 Million USD | 7.2% |
| 1990 Q4 | 628 Million USD | 9.98% |
| 1990 Q3 | 571 Million USD | 3.63% |
| 1990 FY | 628 Million USD | 21.24% |
| 1990 Q1 | 514 Million USD | -0.77% |
| 1989 Q4 | 518 Million USD | 0.0% |
| 1989 FY | 518 Million USD | -46.21% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AstraZeneca PLC | 28.58 Billion USD | -45.072% |
| CSPC Pharmaceutical Group Limited | 99.64 Million USD | -41511.314% |
| Clarus Therapeutics Holdings, Inc. | 42.26 Million USD | -97995.531% |
| Novartis AG | 26.34 Billion USD | -57.371% |
| PT Kalbe Farma Tbk. | 40.4 Million USD | -102519.022% |